160 related articles for article (PubMed ID: 22544189)
1. Implementing early-warning indicators of HIV drug resistance in the Caribbean.
Jack N; Ravasi G; Schrooten W; Sutherland D; Ghidinelli M; Del Riego A
Clin Infect Dis; 2012 May; 54 Suppl 4():S290-3. PubMed ID: 22544189
[TBL] [Abstract][Full Text] [Related]
2. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
[TBL] [Abstract][Full Text] [Related]
3. Combining cohort analysis and monitoring of HIV early-warning indicators of drug resistance to assess antiretroviral therapy services in Vietnam.
Do TN; Nguyen TM; Do MH; Masaya K; Dang TB; Pham TL; Yoshikawa K; Cao TT; Nguyen TT; Bui DD; Nguyen VK; Nguyen TL; Fujita M
Clin Infect Dis; 2012 May; 54 Suppl 4():S306-12. PubMed ID: 22544193
[TBL] [Abstract][Full Text] [Related]
4. Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008.
Ma Y; Zhang F; Li H; Wu H; Zhang J; Ding Y; Zhao D; Fang H; Zhou S; Liu Z; Zhang L; Osborne C; Seguy N; Zhao Y
Clin Infect Dis; 2012 May; 54 Suppl 4():S300-2. PubMed ID: 22544191
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
[TBL] [Abstract][Full Text] [Related]
6. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe.
Dzangare J; Gonese E; Mugurungi O; Shamu T; Apollo T; Bennett DE; Kelley KF; Jordan MR; Chakanyuka C; Cham F; Banda RM
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S313-6. PubMed ID: 22544194
[TBL] [Abstract][Full Text] [Related]
8. Early warning indicators for HIV drug resistance in Malawi.
Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
[TBL] [Abstract][Full Text] [Related]
9. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries.
Bennett DE; Jordan MR; Bertagnolio S; Hong SY; Ravasi G; McMahon JH; Saadani A; Kelley KF
Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S280-9. PubMed ID: 22544188
[TBL] [Abstract][Full Text] [Related]
10. Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008-2010: lessons and challenges for low-resource settings.
Fokam J; Billong SC; Bissek AC; Kembou E; Milenge P; Abessouguie I; Nkwescheu AS; Tsomo Z; Aghokeng AF; Ngute GD; Ndumbe PM; Colizzi V; Elat JB
BMC Public Health; 2013 Apr; 13():308. PubMed ID: 23565992
[TBL] [Abstract][Full Text] [Related]
11. Experience in piloting HIV drug resistance early warning indicators to improve the antiretroviral program in Papua New Guinea.
Daoni E; Kitur U; Parunga A; Ndenzako F; Lloyd A; Yu D
Clin Infect Dis; 2012 May; 54 Suppl 4():S303-5. PubMed ID: 22544192
[TBL] [Abstract][Full Text] [Related]
12. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
13. Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean.
Ravasi G; Jack N; Alonso Gonzalez M; Sued O; Pérez-Rosales MD; Gomez B; Vila M; Riego Ad; Ghidinelli M
Rev Panam Salud Publica; 2011 Dec; 30(6):657-62. PubMed ID: 22358418
[TBL] [Abstract][Full Text] [Related]
14. Early warning indicators for HIV drug resistance in adults in South Africa at 2 pilot sites, 2008-2010.
Dube NM; Tint KS; Summers RS
Clin Infect Dis; 2014 Jun; 58(11):1607-14. PubMed ID: 24585566
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
Kamoto K; Aberle-Grasse J;
Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition.
St-Jean M; Harrigan PR; Sereda P; Montaner J; Lima VD
HIV Med; 2017 May; 18(5):342-353. PubMed ID: 27704659
[TBL] [Abstract][Full Text] [Related]
18. Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations.
Asio J; Watera C; Namuwenge N; Kirungi W; Musinguzi J; Mugagga K; Busobozi R; Tusiime BJ; Lutalo T; Mbidde EK; Kaleebu P;
PLoS One; 2020; 15(4):e0230451. PubMed ID: 32287264
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia.
Mutenda N; Bukowski A; Nitschke AM; Nakanyala T; Hamunime N; Mekonen T; Tjituka F; Mazibuko G; Mwinga S; Mabirizi D; Sagwa E; Indongo R; Dean N; Jordan MR; Hong SY
PLoS One; 2016; 11(12):e0166649. PubMed ID: 27906995
[TBL] [Abstract][Full Text] [Related]
20. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
